Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

OBJECTIVE: To evaluate the cost-effectiveness of obinutuzumab in combination with chlorambucil (GClb) versus rituximab plus chlorambucil (RClb) in the treatment of adults with previously untreated chronic lymphocytic leukemia (CLL) and with comorbidities that make them unsuitable for full-dose fluda...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinicoecon Outcomes Res
Hauptverfasser: Casado, Luis Felipe, Burgos, Amparo, González-Haba, Eva, Loscertales, Javier, Krivasi, Tania, Orofino, Javier, Rubio-Terres, Carlos, Rubio-Rodríguez, Darío
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036824/
https://ncbi.nlm.nih.gov/pubmed/27703384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S114524
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge